Home › Funds › GSA CAPITAL PARTNERS LLP › ELV

GSA CAPITAL PARTNERS LLP position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

GSA CAPITAL PARTNERS LLP reported holding 9,037 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q2 2026 13F filing — a position valued at US$3.5M, representing 0.22% of its reported portfolio and ranking #43 among its reported holdings. GSA CAPITAL PARTNERS LLP has disclosed ELV holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.04K sh
Reported value held$3.50M
Portfolio Weight0.22%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GSA CAPITAL PARTNERS LLP's ELV position evolved

GSA CAPITAL PARTNERS LLP first disclosed a stake in ELV in Q3 2023 at 611 shares (US$266K). The position peaked in Q2 2026 at 9,037 shares, worth US$3.5M. Across 8 filings, GSA CAPITAL PARTNERS LLP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,037 shares valued at US$3.5M — an increase of 6,761 shares quarter over quarter.. Notable position changes include a 146% increase in Q4 2024 (shares rose 18% over the following quarter), a 267% increase in Q1 2026 (shares rose 33% over the following quarter), a 297% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 611 $266.00K New
Q3 2024 996 $518.00K New
Q4 2024 2.45K $904.00K Add
Q2 2025 1.16K $453.00K New
Q3 2025 2.08K $673.00K Add
Q4 2025 620 $217.00K Reduce
Q1 2026 2.28K $666.00K Add
Q2 2026 9.04K $3.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has GSA CAPITAL PARTNERS LLP held ELV?

GSA CAPITAL PARTNERS LLP has disclosed ELV holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is GSA CAPITAL PARTNERS LLP's current position in ELV?

As of Q2 2026, GSA CAPITAL PARTNERS LLP holds 9.04K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $3.50M, representing 0.22% of its reported portfolio and ranking #43.

Has GSA CAPITAL PARTNERS LLP been buying or selling ELV?

In the latest 13F filing (Q2 2026), GSA CAPITAL PARTNERS LLP increased its position in ELV. The position peaked in Q2 2026 at 9.04K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.